PRLD RSI Chart
Last 7 days
10.7%
Last 30 days
-1.2%
Last 90 days
-10.8%
Trailing 12 Months
-26.0%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 04, 2024 | huang jane | sold (taxes) | -15,864 | 4.74 | -3,347 | president, cmo |
Apr 04, 2024 | huang jane | acquired | - | - | 9,375 | president, cmo |
Jan 04, 2024 | huang jane | sold (taxes) | -14,491 | 3.77 | -3,844 | president, cmo |
Jan 04, 2024 | huang jane | acquired | - | - | 9,375 | president, cmo |
Oct 04, 2023 | huang jane | acquired | - | - | 9,375 | president, cmo |
Jul 04, 2023 | huang jane | acquired | - | - | 9,375 | president, cmo |
Jul 04, 2023 | huang jane | sold (taxes) | -15,075 | 4.65 | -3,242 | president, cmo |
May 25, 2023 | vaddi krishna | bought | 4,779 | 5.31 | 900 | ceo |
May 24, 2023 | vaddi krishna | bought | 5,011 | 5.0114 | 1,000 | ceo |
May 24, 2023 | lim bryant david | bought | 12,936 | 5.39 | 2,400 | chief legal officer, corp sec. |
Which funds bought or sold PRLD recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -50.3 | -63,133 | 77,679 | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -38.91 | -3,366 | 7,091 | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | added | 5.04 | 68,724 | 482,769 | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | added | 3.97 | 38,357 | 287,230 | -% |
May 15, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | reduced | -16.91 | -49,294 | 585,864 | 0.01% |
May 15, 2024 | ORBIMED ADVISORS LLC | unchanged | - | 5,127,350 | 51,709,900 | 0.95% |
May 15, 2024 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | unchanged | - | 1,942,510 | 19,590,400 | 0.34% |
May 15, 2024 | Royal Bank of Canada | reduced | -77.29 | -29,000 | 10,000 | -% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | reduced | -2.93 | 22,988 | 319,604 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | reduced | -68.75 | -265,832 | 141,228 | -% |
Unveiling Prelude Therapeutics Incorporated's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Date Filed | Form Type | Document | |
---|---|---|---|
Peers (Alternatives to Prelude Therapeutics Incorporated)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Prelude Therapeutics Incorporated News
Balance Sheet | ||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2018Q4 |
Assets | -11.0% | 247 | 278 | 259 | 281 | 198 | 221 | 242 | 259 | 281 | 305 | 331 | 350 | 370 | 224 | 240 | 167 | 94.00 | 22.00 | 16.00 |
Current Assets | -12.8% | 205 | 236 | 235 | 260 | 175 | 204 | 227 | 249 | 270 | 295 | 326 | 345 | 365 | 221 | 238 | - | - | 20.00 | 16.00 |
Cash Equivalents | -2.3% | 25.00 | 25.00 | 16.00 | 26.00 | 18.00 | 31.00 | 52.00 | 51.00 | 52.00 | 32.00 | 61.00 | 343 | 363 | 218 | 235 | - | - | 19.00 | 16.00 |
Net PPE | -0.4% | 7.00 | 7.00 | 7.00 | 6.00 | 5.00 | 5.00 | 5.00 | 4.00 | 4.00 | 4.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | - | - | 2.00 | 1.00 |
Liabilities | -10.4% | 36.00 | 41.00 | 20.00 | 19.00 | 23.00 | 25.00 | 25.00 | 18.00 | 19.00 | 19.00 | 20.00 | 15.00 | 13.00 | 11.00 | 11.00 | 9.00 | 7.00 | 5.00 | 3.00 |
Current Liabilities | -19.2% | 18.00 | 22.00 | 17.00 | 15.00 | 20.00 | 22.00 | 22.00 | 16.00 | 16.00 | 19.00 | 20.00 | 15.00 | 12.00 | 11.00 | 11.00 | - | - | 5.00 | 2.00 |
Shareholder's Equity | -11.1% | 211 | 237 | 238 | 262 | 175 | 195 | 217 | 241 | 262 | 286 | 311 | 334 | 357 | 212 | 228 | - | - | - | - |
Retained Earnings | -6.9% | -487 | -456 | -423 | -392 | -362 | -334 | -305 | -275 | -248 | -219 | -186 | -155 | -128 | -107 | -88.18 | - | - | -50.50 | -22.93 |
Additional Paid-In Capital | 0.8% | 699 | 693 | 662 | 655 | 538 | 532 | 526 | 519 | 513 | 506 | 498 | 490 | 485 | 320 | 316 | - | - | 1.00 | 0.00 |
Shares Outstanding | 25.5% | 76.00 | 60.00 | 57.00 | 52.00 | 48.00 | 47.00 | 47.00 | 47.00 | 47.00 | 46.00 | 46.00 | 46.00 | - | - | - | - | - | - | - |
Float | - | - | - | - | 77.00 | - | - | - | 65.00 | - | - | - | 343 | - | - | - | - | - | - | - |
Cashflow (Quarterly) | |||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2018Q4 |
Cashflow From Operations | -34.8% | -31,791 | -23,578 | -25,683 | -27,668 | -30,134 | -22,927 | -20,439 | -18,468 | -21,895 | -25,702 | -21,774 | -19,912 | -16,143 | -14,847 | -12,507 | -8,902 | -9,921 | - | - | - |
Share Based Compensation | -6.2% | 5,547 | 5,912 | 6,715 | 6,733 | 6,256 | 5,845 | 6,442 | 6,028 | 6,829 | 4,468 | 7,033 | 4,237 | 6,500 | 3,122 | 1,472 | 627 | 362 | - | 297 | - |
Cashflow From Investing | 303.6% | 31,221 | 7,736 | 15,045 | -75,426 | 17,999 | 1,355 | 21,607 | 58,576 | 153 | -1,804 | -260,632 | -381 | -986 | -329 | -170 | -42.00 | -80.00 | - | - | - |
Cashflow From Financing | -100.1% | -14.00 | 25,237 | 88.00 | 111,339 | -269 | 155 | 148 | -41,036 | 41,548 | 1,954 | 711 | 422 | 161,810 | -1,307 | 217,753 | -65.00 | 29,847 | - | - | - |
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development | $ 27,409 | $ 21,834 |
General and administrative | 6,934 | 7,281 |
Total operating expenses | 34,343 | 29,115 |
Loss from operations | (34,343) | (29,115) |
Other income, net | 2,912 | 1,397 |
Net loss | $ (31,431) | $ (27,718) |
Per share information: | ||
Net loss per share of common stock, basic | $ (0.42) | $ (0.58) |
Net loss per share of common stock, diluted | $ (0.42) | $ (0.58) |
Weighted average common shares outstanding, basic | 75,735,954 | 47,737,190 |
Weighted average common shares outstanding, diluted | 75,735,954 | 47,737,190 |
Comprehensive loss | ||
Net loss | $ (31,431) | $ (27,718) |
Unrealized (loss) gain on marketable securities, net of tax | (458) | 1,294 |
Comprehensive loss | $ (31,889) | $ (26,424) |
BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 24,707 | $ 25,291 |
Marketable securities | 177,217 | 207,644 |
Prepaid expenses and other current assets | 3,442 | 2,654 |
Total current assets | 205,366 | 235,589 |
Restricted cash | 4,044 | 4,044 |
Property and equipment, net | 7,294 | 7,325 |
Right-of-use asset | 30,107 | 30,412 |
Other assets | 295 | 295 |
Total assets | 247,106 | 277,665 |
Current liabilities: | ||
Accounts payable | 5,308 | 4,580 |
Accrued expenses and other current liabilities | 10,147 | 15,768 |
Operating lease liability | 2,188 | 1,481 |
Total current liabilities | 17,643 | 21,829 |
Other liabilities | 3,277 | 3,339 |
Operating lease liability | 15,452 | 15,407 |
Total liabilities | 36,372 | 40,575 |
Commitments (Note 8) | ||
Stockholders’ equity: | ||
Additional paid-in capital | 698,785 | 693,252 |
Accumulated other comprehensive (loss) income | (235) | 223 |
Accumulated deficit | (487,821) | (456,390) |
Total stockholders’ equity | 210,734 | 237,090 |
Total liabilities and stockholders’ equity | 247,106 | 277,665 |
Voting Common Stock | ||
Stockholders’ equity: | ||
Common stock | 4 | 4 |
Non-voting Common Stock | ||
Stockholders’ equity: | ||
Common stock | $ 1 | $ 1 |